Angio-Seal Evolution Device Registry

Completed

Conditions studied: Peripheral Vascular Disease, Coronary Artery Disease, Peripheral Artery Disease, Arterial Occlusive Disease, Coronary Heart Disease

In brief

Collect data on the use of the Angio-Seal Evolution Device in diagnostic and interventional patient populations.

Key facts

Study ID

NCT00817349

Run by

Abbott Medical Devices

People needed

1004

Starts

2008-07-01

Expected to finish

2010-04-01

Last updated by the study team

2019-02-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is having a diagnostic and/or interventional procedure via femoral artery access.

You may not qualify if…

• Patients who are unable to provide written informed consent.

Where it is running

• Good Samaritan Hospital — Los Angeles, California, United States
• Michigan Heart, P.C. — Ypsilanti, Michigan, United States
• Cooper Health System — Camden, New Jersey, United States
• Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
• Altru Health System Hospital — Grand Forks, North Dakota, United States
• Ohiohealth Research Institute @ Riverside Methodist Hospital — Columbus, Ohio, United States
• Providence Health & Services — Portland, Oregon, United States
• Main Line Health Heart Center: Bryn Mawr Hospital — Bryn Mawr, Pennsylvania, United States
• Main Line Health Heart Center: Lankenau Hospitals — Wynnewood, Pennsylvania, United States
• Baptist Hospital West — Knoxville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.